F18-Pivalate

N/A

Report date: 2025/11/25 15:53:41

NME

Base Information

Drug NameF18-Pivalate

Drug Alias NameRAD-101

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionRadionuclide imaging enhancersFatty acid synthase modulators

TargetsFatty acid synthase

Therapy Area/IndicationsBrain metastasesNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadiopharm Theranostics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRadiopharm Theranostics Ltd

Inactive CompaniesN/A

Active IndicationsBrain metastasesNeoplasm Metastasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A